[Surgical therapy for ischemic cardiomyopathy]

Area of Science:

• Cardiology
• Cardiac Surgery
• Heart Failure Management

Context:

• Ischemic cardiomyopathy (ICM) presents a significant challenge in heart failure treatment.
• The efficacy of surgical ventricular restoration (SVR) combined with coronary artery bypass grafting (CABG) remains debated.
• Previous trials like STICH have yielded mixed results regarding the benefits of adding SVR to CABG.

Purpose:

• To investigate the efficacy of combining CABG with SVR for patients suffering from ICM.
• To evaluate the impact of SVR on symptom relief, left ventricular function, and long-term survival in ICM patients.

Summary:

• A retrospective study of 24 ICM patients undergoing CABG with or without SVR was conducted.
• Patients receiving CABG with SVR showed significant relief in cardiac symptoms and reduction in left ventricular end-systolic volume index (LVESVI).
• SVR demonstrated particular benefit in patients with smaller left ventricular end-diastolic dimensions (LVDd < 60 mm), improving symptoms and function.

Impact:

• SVR, when added to CABG, offers significant symptomatic relief and functional improvement in select ICM patients, especially those with dilated cardiomyopathy.
• The findings suggest SVR can enhance long-term survival beyond what CABG alone provides.
• This study highlights the potential of SVR as a valuable adjunct therapy for specific ICM patient populations.